Search results for

The Republican tax plan could reduce or eliminate federal tax credits that reward companies for developing drugs to treat rare diseases. People who benefit from the medicines have objected.

Steve Inskeep talks to Norman Eisen and Richard Painter, ethics lawyers for the Obama and George W. Bush presidencies, about financial disclosures that show Trump's administration is the richest ever.

President Trump says his effort to help Chinese telecommunications company ZTE is only part of a "larger trade deal." NPR's Rachel Martin talks with Robert Daly of the Wilson Center.

In 2018, the Trump administration made good on its promises to unwind long-standing U.S. commitments to guarantee global security and prosperity, writes Ted Piccone of the Brookings Institution.

A new biopic tells the story of Ray Kroc, who turned a single burger restaurant into a multi-billion dollar worldwide franchise. Critic David Edelstein says The Founder offers a dark dose of realism.

An Oakland native and her father each came of age a generation apart in a city that was becoming more African-American. She reflects on the city as it was and as it is today.

In 2006, Oregon successfully made pseudoephedrine, a key ingredient of meth, a prescription drug. Since then, Mother Jones' Jonah Engle reports, 24 states have tried to follow suit — and 23 have failed. Engle attributes those failures to pharmaceutical companies' massive lobbying efforts.

NPR's Leila Fadel talks to professor Brenda Estefan and Lila Abed of the Wilson Center's Mexico Institute, about the cross-border concerns framing Mexico's election.

The U.S. job market is white-hot, with over 300,000 jobs added to the economy last month alone. We hear from some recently-hired Americans about their experiences in getting hired for their new jobs.

Journalist Karen Hao has written a book called "Empire of AI," which details the world of Sam Altman's OpenAI.